637334-45-3 Ocrelizumab
BD01278581637334-45-398%
登录 1mg
174722-31-7 Rituximab
BD01146378174722-31-79.2-10.8mg/mL
登录 50mg
1174014-05-1 Ublituximab
BD016995691174014-05-195%
登录
679818-59-8 Ofatumumab
BD01113187679818-59-897%
登录 1mg
1169956-08-4 Ocaratuzumab
BD015995331169956-08-495%
登录
2254061-60-2 Divozilimab
BD017190752254061-60-295%
登录
949142-50-1 Obinutuzumab
BD01135322949142-50-197%
登录 1mg
1